icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
 
 
  Reported by Jules Levin
EASL 2013 April 28 Amsterdam
 
K Rutter1, A Ferlitsch1, A Maieron2, AF Stattermayer1, I Graziadei3, M Dulic4, M Gschwantler4, R Stauber5, H Hofer1, M Peck-Radosavljevic1, W Vogel3, M Trauner1,
P Ferenci1
1Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria, 2Hospital Elisabethinen Linz, Austria, 3Medical University of Innsbruck, Division of Gastroenterology and Hepatology, Austria, 4Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria, 5Medical University of Graz, Department of Gastroenterology and Hepatology, Austria

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif